Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Items 701–800 of 805
Zhong, Y., Feng, C., Lisha, H., Yang, M., Zhang, X., Wu, J., Dong, B., Jia, P., Yang, S., & Dou, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26728270
Li, W., Shen, C., Kong, W., Zhou, X., Fan, H., Zhang, Y., Liu, Z., & Zheng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26517820
Self-citationWelke bloeddruk bij kwetsbare oudere patiënten? een kritische blik op streefwaarden
Claassen, J., Richard, E., Mooijaart, S. P., & van Charante, E. P. M. (2023) · Leiden Repository (Leiden University)
ACCOGLI, P. (2024) · Electronic Theses and Dissertations Repository (University of Pisa)
Ibrahima, S., Ba, H., Traoré, D., Guindo, A., Dembélé, I., Diarra, B., Doumbia, M. K., Traoré, F., Coulibaly, I., Camara, M., et al. (2025) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2025.1512057
Rittig, K., Adili, F., Zähringer, M., Malyar, N. M., Rother, U., Balletshofer, B. M., Qiu, H. J., Reimer, P., & Lawall, H. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2593-4467
Management of Hypertension: Making Sense of the Multiple Guidelines
Atal, S., Shetty, S., & Shukla, A. K. (2025) · Journal of Clinical and Preventive Cardiology · doi:10.4103/jcpc.jcpc_46_25
Intensive Blood Pressure Targets in Geriatrics: Individualized Decision‐Making and Unresolved Risks
Akçay, Ö. F. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70261 · Cited by 1
“The STEP trial in older Chinese adults demonstrated cardiovascular benefits of intensive control but at the expense of increased hypotension and renal events [6].”
Zheng, K., Mo, S., Zheng, W., Li, J., Miao, Z., Lu, X., He, H., Cao, Y. B., Zhao, B., Levitt, M. R., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1627936
“Similarly, the STEP trial (target 110–130 mmHg) reduced major cardiovascular events, including stroke, while the BPROAD trial found that intensive BP lowering reduced such events in patients with diabetes (13, 14).”
Khan, A. M., Villalobos, A., Kakadiya, A. D., Kaur, H., Tabassum, S., Faisal, A. M., Pardeshi, R., Shah, D., Ponnada, S. C., & Patel, K. (2026) · Current Cardiology Reviews · doi:10.2174/011573403x391863251015111807
Tian, X., Wu, S., Xia, X., Xu, Q., Chen, S., Wang, A., & Fang, R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70472
Self-citationXia, X., Chen, S., Tian, X., Xu, Q., Li, H., Zhang, Y., Zhang, X., Li, J., Wu, S., & Wang, A. T. (2026) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.10.022
Self-citationZhang, Y., Zhang, Y., Yang, S., Gan, X., Huang, Y., Zhang, Y., Wu, Y., Hou, F. F., & Qin, X. (2026) · BMJ Medicine · doi:10.1136/bmjmed-2025-001791
Rittig, K., Adili, F., Zähringer, M., Malyar, N. M., Rother, U., Balletshofer, B. M., Qiu, H. J., Reimer, P., Lawall, H., (DDG), D. D. G., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01427-0
Primary Prevention in Older Adults
Parsons, B., Soni, S., Rao, S., & Mehta, A. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.12.010
Eschenhagen, T., & Weil, J. (2026) · Springer eBooks · doi:10.1007/978-3-662-72738-6_6
Evaluation and Management of Hypertension in Older Adults
Petriceks, A. H., Berlot, A., Mason, T., Marion, W., Corbett, C., & Juraschek, S. P. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2025.12.004 · Cited by 1
After 6 Decades of Blood Pressure Management, Why Is Achieving Control Still So Difficult?
Rose, A. J., & Rothberg, M. B. (2026) · Journal of General Internal Medicine · doi:10.1007/s11606-026-10294-w
Pulse pressure and cardiovascular morbidity in older adults Huacho 2025
Perez, E. M. F. (2025) · Universidad Peruana Cayetano Heredia Institutional Repository
Liu, S., Yin, Y., Yang, H., Sun, L., (5906), J. W., Zhou, Y., Guan, L., Xing, L., Xie, Z., Ye, N., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04678-2 · Cited by 1
Self-citationPreferences for Antihypertensive Prescribing in Older Adults
O’Hagan, E. T., Livingstone, A., Gadsden, T., Usherwood, T., Nguyen, T. N., Schutte, A. E., Tiedemann, A., Lindley, R. I., Rodgers, A., Jan, S., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.01.044 · Cited by 1
Prevention of Heart Failure in People With Diabetes
Pandey, A., & Hernandez, A. F. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00015-x
Berg, D. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-87862-3.00008-2
Ling, Q., Deng, Y., Dong, X., Song, Q., & Cai, J. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.125.041556
Self-citation(2026) · Canadian Family Physician · doi:10.46747/cfp.7203156
Vijaykumar, V. (2026) · Cureus · doi:10.7759/cureus.105433
“…trials (e.g., SPRINT, STEP, and ACCORD-BP) and meta-analyses [1-3, 7, Randomized trials collectively demonstrate that intensive blood pressure lowering clearly reduces major cardiovascular outcomes in specific populations, such as high-risk adults without diabetes and fit older adults [3,7].”
InfluentialZhao, J., Zhang, X., Zhang, L., Wu, S., Chen, S., Zhao, L., Chen, B., & Li, W. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110956
Self-citationYan, C., Peng, Q., Wang, X., Wei, Z., Yu, C., Wang, T., Zhu, L., Bao, H., Cheng, X., & Yu, J. (2026) · Maturitas · doi:10.1016/j.maturitas.2026.108920
Self-citationKim, H. J., Kim, H. M., & Kim, D.-H. (2026) · Advances in Therapy · doi:10.1007/s12325-026-03573-9
Safe prescribing of antihypertensive drugs in the elderly and managing the risk of adverse events
Passey, S., Erum, M., Patel, N., Chopra, S., Jain, H., Jha, J., Kingma, T. J., Kholoki, O., Pillai, A. A., Venkataramanan, S. V. A., et al. (2026) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2026.2653753 · Cited by 1
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial [14] studied Chinese patients aged 60–80 years, comparing an intensive systolic BP target of 110–130 mmHg with a standard target of 130–150 mmHg.”
Blood Pressure Control and Mortality Among US Veterans
Yamada, M., Griffin, B. R., Shi, Q., Sambharia, M., Swee, M. L., Good, M. K., Kennelty, K. A., Faro, E. Z., Reisinger, H. S., Girotra, S. R., et al. (2026) · Hypertension · doi:10.1161/hypertensionaha.125.25787
Blood Pressure Control Trajectories and Cardiovascular Risk
Cheng, J. S.-C., Chen, J., & He, J. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.01.065
Linh, N. L., Ba, P. N. N., Dang, U., Nguyen, N. G. U. Y. E. N., Truong, T. N., Nguyen, T. T., Le, T. D. V., Tran, K. D. D., Huynh, D. B., Dinh, T. S., et al. (2026) · TTU Journal of Science · doi:10.53901/tjs.2026.01.art05
General practitioners' opinion on antihypertensive drugs deprescribing
Николаевна, А. О., Osipova, I. V., Молчанова, А. А., & Медведева, К. А. (2026) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2026-2570
Li, M., Shi, J., Chen, M., He, Q., Wang, B., Zhao, S., Li, Y., Zhao, Y., & Zhang, Y. (2026) · Pulse · doi:10.1159/000551995
Self-citationĐiều trị dược lý cho bệnh tăng huyết áp ở người lớn tuổi
1, N. Đ. H., 2, H. A. T., 2, H. V. M., Huế, 1. B. V. T. Ư., & Huế, 2. T. Đ. H. Y. D. (2025) · Tạp chí Tim Mạch Học Việt Nam · doi:10.58354/jvc.119.2025.1023
Chen, S., Ji, Y., Yang, R., Peng, X., Bai, J., Fan, X., Song, Q., & Cai, J. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.04.005
Self-citationWang, H., Li, S., Sun, Y., Li, Y., Bilige, W., Qi, F., Xie, L., Wu, G., Yan, H., Yang, Y., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02596-7
Self-citationZhang, Y., Li, S., Zhang, H.-W., Guo, Y., Wu, N., Zhu, C., Xu, R., Qian, J., Dou, K.-F., & Li, J. (2026) · npj Cardiovascular Health · doi:10.1038/s44325-026-00118-5
Ivensky, V., Hundemer, G. L., Leung, A. A. C., Tsuyuki, R. T., & Goupil, R. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.04.034 · Cited by 3
CSC Guidelines for Percutaneous Coronary Intervention (2025)
Fu, X., Chinese Medical Association Chinese Society of Cardiology, & Editorial Board of Chinese Journal of Cardiology (2026) · Cardiology Discovery · doi:10.1097/cd9.0000000000000194
Zhuang, M., Peng, X., Song, Q., Bai, J., Yu, M., & Cai, J. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004118
“[3] 7] Moreover, effective blood pressure (BP) control plays a critical role in preventing the onset and progression of renal impairment.”
Self-citationImplementation Strategies for Intensive Blood Pressure Control
Zuo, Y.-J., & Wang, J.-G. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.03.041
Saely, C. H., Schernthaner, G.-H., Brix, J. M., Klauser‐Braun, R., Zitt, E., Drexel, H., & Schernthaner, G. (2026) · Wiener klinische Wochenschrift · doi:10.1007/s00508-026-02719-7
Luo, D., Liu, H., Zhang, J., Zhang, N., Zhao, Z., Wang, H. X., Liu, Y., Wang, G., Chen, S. H., Liu, E., et al. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag050
Self-citationMaimaitiwusiman, Z., Xuekelati, S., Wumaier, A., Bai, X., Ma, L. H., Li, Y., Aerken, A., Yang, Y., & Wang, H. B. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-102957
Self-citationZhu, Y., Nie, Z., Zhou, D., Yan, M., Wang, J., Cai, A., Huang, Y. Q., Luo, S., Ou, Y., & Feng, Y. (2026) · Journal of Clinical Hypertension · doi:10.1111/jch.70275 · Cited by 1
Self-citationZoysa, P. D., Weerarathna, T., Darshana, I., Egodage, U., Rathnayake, R., Jayasekara, M. M. P. T., Sujanitha, V., Matthias, A., Ratnayake, B., Mayurathan, P., et al. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06062-7
Li, L., Zhang, J., Yu, H., Xu, Y., Ma, Z., Zheng, G., Liu, T., Jiang, J., Wu, S., Xia, Y., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101430
“Notably, optimizing SBP targets to 110-130 mmHg (vs. conventional 120-140 mmHg) nearly tripled life expectancy benefits (3.61 vs. 1.51 years), aligning with SPRINT[25]/STEP[26] trial evidence of 26-27% cardio-vascular risk reduction26,28.”
InfluentialSelf-citationHypertension management: is lower always better?
Shamsulddin, A. B. (2026) · Minerva Medica · doi:10.23736/s0026-4806.26.09891-5
Wu, W., (417962), P. F., Cai, Z., Wang, Y., Wu, K., Zheng, H., Chen, G., Chen, Z., Lan, Y., Chen, Y., et al. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00302-7
Self-citationDobracka, A., Bojanowski, H. T., Gawron, N., Sito, M., Czmyr, J., Marczak, Z., Jarowicz, M., Wójcik, Ł., Jurkowski, F., & Zachar, K. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.92.72527
Intensive blood pressure control in type 2 diabetes: a meta-analysis of randomized controlled trials
Liu, Z. H., Junfeng, W., & Niu, C. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1850865
Ciobanu, A. O., Vittos, O., Dolofan, B., Trambitas, N., Tănăsescu, R., Guja, C., & Vinereanu, D. (2026) · Atherosclerosis Plus · doi:10.1016/j.athplu.2026.100573
Телемедицина в управлении гипертонической болезнью: перспективы и эффективность
Александровна, Е. И., Фатенков, О. В., Губарева, И. В., Дьячков, В. А., Fatenkov, G. O., & Евгеньевна, К. О. (2025) · Practical medicine
Galle, J., & Weinmann-Menke, J. (2026) · Die Innere Medizin · doi:10.1007/s00108-026-02144-y
Mavraganis, G., Fragoulis, C., Georgiopoulos, G. A., Mavromoustakou, K., Dimitriadis, K. P., Aznaouridis, K. A., Chrysohoou, C. A., Stamatelopoulos, K. S., & Tsioufis, K. P. (2026) · Medicina · doi:10.3390/medicina62071222
“Evidence supporting these recommendations demonstrates that intensive BP control reduces the incidence of CV events, including stroke, myocardial infarction, and HF hospitalization [5,6].”
Huang, A. L., & Vongpatanasin, W. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00059-7
Kang, S. H., Park, S. Y., Lim, Y. J., Choi, J. Y., Kim, B. Y., & Do, J. Y. (2026) · International Urology and Nephrology · doi:10.1007/s11255-026-05201-5
Голод, Н. Р., Kalmykova, Y., Дубинська, О. Я., Салатенко, І., & Rusyn, L. (2026) · Physical rehabilitation and recreational health technologies · doi:10.15391/prrht.2026-11(3).02
Hypertension in Advanced Chronic Kidney Disease: Saving the Kidneys or the Heart?
Tantisattamo, E., & Ku, E. (2026) · Advances in Kidney Disease and Health · doi:10.1053/j.akdh.2026.02.003
Updates in the Diagnosis and Management of Hypertension: A Review of Recent Guidelines
Kavia, J., Mittal, R., & Kaplan, J. M. (2026) · British Journal of Hospital Medicine · doi:10.31083/bjhm55374
Current Issues in Hypertension Management in Older Adults
Benenson, I., Vargas, P., & Prado, K. (2026) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2026.105918
Intensive blood pressure control is beneficial for preventing stroke in patients with dementia
Mogi, M. (2026) · Hypertension Research · doi:10.1038/s41440-026-02727-0
Patel, J., Pichardo-Gonzalez, R., Camp, S., Tran, Q. K., Ather, A., Steckler, L. E., Raj, D. S., & Pourmand, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145380
“Similarly, the STEP trial found reduced adverse events with SBP 110–130 mmHg compared with SBP 130–150 mmHg in healthy adults aged 60–80 without major comorbidities such as heart failure or advanced kidney disease [11].”
Jang, M., Park, S., Ann, S. H., Kim, Y., Jeon, Y., Lim, S., Kwon, W.-J., Choi, S. H., Park, H. W., & Park, G. (2026) · PLoS ONE · doi:10.1371/journal.pone.0353359
“Recent trials have demonstrated that intensive blood pressure control reduces the risk of atherosclerotic cardiovascular disease (ASCVD), leading current guidelines to recommend lower BP targets [13–16].”
Socioeconomic gradients in hypertension prevalence and management: a cross-sectional study
Kim, E., Lee, H., Jung, Y., & Kim, H. C. (2026) · BMC Public Health · doi:10.1186/s12889-026-28502-x
Survival as a source of confounding, selection bias, and effect modification
Schooling, C. M., & Yang, G. (2026) · International Journal of Epidemiology · doi:10.1093/ije/dyag099
“In contrast, trials have increasingly shown benefits in older people of treating hypertension [20] and adiposity [21].”
Envelhecimento e doenças cardiovasculares: aspectos clínicos e estratégias de prevenção
da Silva, M. D. C. R. G., Ribeiro, K. D. B., Rolim, N. R. F., Almeida, J. V. S., & de Araújo, S. T. (2026) · Revista fisio&terapia. · doi:10.69849/8pz5wx70
Management von erhöhtem Blutdruck und Bluthochdruck: Risikoreduktion im Fokus
Schmieder, R. S., & Schunkert, H. (2026) · Herz · doi:10.1007/s00059-026-05385-7
Cost-Effectiveness of Radiofrequency Renal Denervation for Resistant Hypertension in Australia
Schlaich, M. P., Ryschon, A. M., Shetty, S. V., Walton, A., Esler, M., Ciorra, A., Hill, M., & Pietzsch, J. B. (2026) · Heart Lung and Circulation · doi:10.1016/j.hlc.2026.04.006
Luangjaru, S., Warodomwichit, D., & Vathesatogkit, P. (2026) · Research Medical Journal · doi:10.33165/rmj.2027.e277636
Turgut, F. H., & Abdel‐Rahman, E. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34069-7.00017-3
Deprescribing of blood pressure-lowering medications in patients with hypotensive syncope
Russo, V., Parente, E., Comune, A., Groppelli, A., Pascual, J. F., Rivas‐Gándara, N., Deharo, J., Maille, B., de Lange, F. J., Boel, T. T., et al. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107119 · Cited by 1
Isolated Diastolic Hypertension and Cardiovascular Disease Risk in Young Adults
Tang, R., An, J., Moran, A. E., Shimbo, D., Allen, N. B., Xanthakis, V., Reynolds, K., & Zhang, Y. (2026) · Hypertension · doi:10.1161/hypertensionaha.126.27333
Ezeugwu, C. O. (2026) · Dialogues in Health · doi:10.1016/j.dialog.2026.100343
“Landmark trials such as SPRINT and STEP demonstrated that intensive BP lowering reduces major cardiovascular events [3,4].”
Management of Hypertension in Older Adults
Seo, J. (2026) · Korean Journal of Geriatrics & Gerontology · doi:10.15656/kjgg.2026.27.2.53
Achieved home systolic blood pressure and cardiovascular risk in older hypertensive patients
Ji, Y., Peng, X., Bai, J., Song, Q., & Cai, J. (2026) · Hypertension Research · doi:10.1038/s41440-026-02787-2
Self-citationSun, G., Guo, X., Zhao, C., Ouyang, N., Li, G., Wang, C., Ren, Y., Xing, L., Sun, Z., Qiao, L., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.082511 · Cited by 1
Self-citationKjeldsen, S. E., Halvorsen, L. V., & Burnier, M. (2026) · Blood Pressure · doi:10.1080/08037051.2026.2728279
(2025) · repository of the Library and Information Centre, Hungarian Academy of Sciences (REAL-J)
Rivasi, G., Salucci, C., D’Ambrosio, G., Gori, V., Capacci, M., Ceccarelli, G., Vinci, M., Giambusso, V. G., Liccardo, A., Bisignano, M. F., et al. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004431
Choudhury, D. M. H. (2025) · Journal of Prevention Diagnosis and Management of Human Diseases · doi:10.55529/jpdmhd.52.80.94
The 2025 AHA/ACC Hypertension Guidelines: Key Updates, Historical Context, and Clinical Implications
Giacona, J. M., & Vongpatanasin, W. (2026) · Current Cardiology Reports · doi:10.1007/s11886-026-02413-0
Gao, Y., Wang, P., Lu, J., Wang, K., Wang, Y., Teng, W., Pan, J., Meng, N., & Wu, Q. (2026) · Experimental Gerontology · doi:10.1016/j.exger.2026.113313
Sriperumbuduri, S., Khan, R. W., Aftab, S., Hiremath, S. S., Dixon, D. L., & Gupta, G. (2026) · American Journal of Hypertension · doi:10.1093/ajh/hpag111
Too much, too soon? The argument against initial combination therapy in stage I hypertension
McClintick, D. J., Bowman, H. C., & Ebinger, J. E. (2026) · Journal of Human Hypertension · doi:10.1038/s41371-026-01221-x
Yang, H., Li, Y., Xiang, G., Pei, S., Wang, M., Xu, L., Zhu, B., Liu, Y., & Yang, X. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1929546
Self-citationSarker, S., Banerjee, S., Herazo, C. A. B., Nawab, J., Afra, M., Rayudu, U. S., Abdelkhalik, A. M. H., Patel, R., Bucataru, L., Khizer, U., et al. (2026) · JRSM Cardiovascular Disease · doi:10.1177/20480040261492364
Pisaruk, A. (2026) · Problems of ageing and longevity (Ukraine) · doi:10.71012/pro-ageing-2026-3-08
Sakata, S. (2026) · Hypertension Research · doi:10.1038/s41440-026-02829-9
Hirohama, D., Shibata, S., Eguchi, N., Hatta, T., Kario, K., Katsuya, T., Kobayashi, K., Nishiyama, A., Noda, M., Nozato, Y., et al. (2026) · Hypertension Research · doi:10.1038/s41440-026-02833-z
Self-citationIatridi, F., Roddick, A., Staplin, N., Che, Z., Liu, J., Arimoto, R., Al-Mohammad, A., Li, Y., Ge, J., Ku, E., et al. (2026) · JAMA Cardiology · doi:10.1001/jamacardio.2026.4445
Self-citationDiretriz Brasileira de Cardiogeriatria – 2026
Helber, I., Zanon, J. C. D. C., Peixoto, J. M., Caixeta, A. M., Nussbacher, A., de Oliveira, D. C., de Freitas, E. V., Cintra, F. D., Garcia, J. S., Miranda, R. D., et al. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20260795
Guananga-Pinto, J. V. (2026) · INNOVATE Research Journal · doi:10.65133/irj.v2.n1.2026/a18
Blood pressure targets in adults with hypertension
Larvie, D. Y., Thompson, W., Grenet, G., Wright, J., Jauca, C. D., Salzwedel, D. M., Adams, S., & Ambasta, A. (2026) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd016397
Rajzer, M., Doroszko, A., Filipiak, K. J. ;. I. N. K., Gąsowski, J., Szyndler, A. K. N. T. I. D., Wizner, B., Dróżdż, T., Wojciechowska, W., Januszewicz, A., Targowski, T., et al. (2022) · Via Medica Journals
Yamamoto, K. (2026) · Hypertension Research · doi:10.1038/s41440-026-02685-7
Castañón, A., Hughes, A., Grašič, K., White, M., Sheppard, J. P., McManus, R. J., Pearson‐Stuttard, J., & Stevens, R. (2026) · PLoS ONE · doi:10.1371/journal.pone.0359861
“Blood pressure (BP) control significantly reduces cardiovascular disease and associated mortality, [3] highlighting the need for accurate diagnosis and treatment.”
Tinoco-Lara, M. A., & Camafort, M. (2026) · International Journal of Heart Failure · doi:10.36628/ijhf.2026.0131
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.